NCT00518336View on ClinicalTrials.gov

Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil

PHASE2CompletedINTERVENTIONAL
Enrollment

433

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

September 30, 2010

Conditions
Infections, Papillomavirus
Interventions
PROCEDURE

Blood sampling

Blood sampling at Visit 3, 5 and 7.

PROCEDURE

Collection of cervical specimen

Collection of cervical specimen at Visit2, 3, 4, 5, 6 and 7.

BIOLOGICAL

Cervarix

Three doses administered intramuscularly at 0, 1 and 6 months.

Trial Locations (5)

80069-900

GSK Investigational Site, Curitiba

90035-903

GSK Investigational Site, Porto Alegre

03015000

GSK Investigational Site, São Paulo

13083-970

GSK Investigational Site, Campinas

Unknown

GSK Investigational Site, Fortaleza

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY